Key result
Cardioversion and diltiazem successfully restore sinus rhythm in exertional AF with sickle cell trait.
Why the study?
Atrial fibrillation is uncommon among young, healthy athletes and its occurrence in individuals with sickle cell trait is not extensively documented.
Case Report (n=1)
This case highlights the rare occurrence of exertional atrial fibrillation with rapid ventricular response in a young athlete with sickle cell trait, emphasizing the utility of guideline-directed rate control and cardioversion.
Answers are grounded in this paper and cite their sources.
SCT may prompt AF evaluation in symptomatic young athletes; this case leaves the association hypothesis-generating pending larger studies.
Sickle cell trait (SCT) is generally regarded as a benign carrier state of sickle cell disease (SCD); however, emerging evidence indicates that it may be associated with adverse cardiovascular outcomes, including atrial fibrillation (AF). AF is uncommon among young, otherwise healthy athletes, and its occurrence in individuals with SCT is not extensively documented. We present a case involving a 22-year-old male collegiate football player with a history of SCT who presented with palpitations initiated during practice. Upon arrival, he was hemodynamically stable; nonetheless, his initial electrocardiogram (ECG) revealed atrial fibrillation with rapid ventricular response (AF RVR). Laboratory investigations were unremarkable, including a normal troponin level. The patient was administered intravenous (IV) diltiazem for rate control, and synchronized cardioversion was successfully performed to restore sinus rhythm. Short-term anticoagulation therapy with apixaban was prescribed, along with flecainide on an as-needed basis for rhythm management. The patient was subsequently referred for outpatient catheter ablation and placed on a three-month restriction from contact sports. This case underscores a rare presentation of AF RVR in a young athlete with SCT. Exertional stress may contribute to arrhythmogenesis through mechanisms such as vaso-occlusion, hypoxia, acidosis, and dehydration. Current guidelines recommend rate control, cardioversion when clinically indicated, and short-term anticoagulation in cases of new-onset AF. Catheter ablation presents a potential definitive therapeutic option for young, symptomatic individuals. Preventive measures for athletes with SCT should include adequate hydration, heat acclimatization, and education of players and coaching staff. This case highlights the importance of heightened awareness, adherence to guideline-based management, and the necessity for further research into the association between SCT and AF in young athletes.
No takes yet. Share an insight, caveat, or question.
Sasser et al. (2025) conducted a case report in Atrial Fibrillation with Rapid Ventricular Response (AF RVR) and Sickle Cell Trait (n=1). Diltiazem and synchronized cardioversion was evaluated on Restoration of normal sinus rhythm. A 22-year-old athlete with sickle cell trait developed exertional atrial fibrillation with rapid ventricular response, which was successfully treated and converted to normal sinus rhythm using diltiazem and synchronized cardioversion.
Synapse has enriched 10 related papers. Consider them for comparative context: